Share on StockTwits

Shares of Amsurg Corp (NASDAQ:AMSG) have received an average recommendation of “Buy” from the nine analysts that are presently covering the company, StockRatingsNetwork.com reports. Four equities research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $52.75.

Shares of Amsurg Corp (NASDAQ:AMSG) traded down 0.31% during mid-day trading on Friday, hitting $45.66. The stock had a trading volume of 3,991,896 shares. Amsurg Corp has a one year low of $35.06 and a one year high of $52.81. The stock’s 50-day moving average is $46.17 and its 200-day moving average is $45.1. The company has a market cap of $1.451 billion and a P/E ratio of 20.36.

Amsurg Corp (NASDAQ:AMSG) last posted its quarterly earnings results on Tuesday, April 22nd. The company reported $0.53 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.55 by $0.02. The company had revenue of $263.11 million for the quarter, compared to the consensus estimate of $272.09 million. During the same quarter in the prior year, the company posted $0.52 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. Analysts expect that Amsurg Corp will post $2.44 EPS for the current fiscal year.

A number of analysts have recently weighed in on AMSG shares. Analysts at SunTrust upgraded shares of Amsurg Corp from a “neutral” rating to a “buy” rating in a research note on Friday. They now have a $54.00 price target on the stock, up previously from $50.00. Separately, analysts at Robert W. Baird upgraded shares of Amsurg Corp from a “neutral” rating to an “outperform” rating in a research note on Friday. They now have a $55.00 price target on the stock, up previously from $44.00. Finally, analysts at Raymond James upgraded shares of Amsurg Corp from a “market perform” rating to a “strong-buy” rating in a research note on Friday, May 30th. They now have a $60.00 price target on the stock.

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (NASDAQ:AMSG) in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.